LifeStance Health Group, Inc.
LFST
$6.45
-$0.08-1.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.85% | 13.39% | 13.86% | 16.31% | 18.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.85% | 13.39% | 13.86% | 16.31% | 18.50% |
| Cost of Revenue | 13.51% | 11.27% | 10.47% | 11.56% | 12.61% |
| Gross Profit | 14.59% | 18.06% | 21.60% | 27.58% | 33.20% |
| SG&A Expenses | 5.91% | 8.16% | 5.58% | 4.49% | 3.79% |
| Depreciation & Amortization | -22.83% | -28.67% | -30.67% | -25.96% | -11.79% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.35% | 7.91% | 6.32% | 6.91% | 8.35% |
| Operating Income | 181.87% | 114.24% | 100.95% | 89.06% | 76.64% |
| Income Before Tax | 121.46% | 86.54% | 86.43% | 79.71% | 72.11% |
| Income Tax Expenses | 1,688.24% | -131.55% | 36.73% | 82.97% | 99.16% |
| Earnings from Continuing Operations | 116.82% | 90.43% | 89.30% | 79.41% | 69.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 116.82% | 90.43% | 89.30% | 79.41% | 69.16% |
| EBIT | 181.87% | 114.24% | 100.95% | 89.06% | 76.64% |
| EBITDA | 90.00% | 160.48% | 3,113.06% | 308.34% | 191.00% |
| EPS Basic | 116.40% | 90.65% | 89.53% | 79.98% | 70.11% |
| Normalized Basic EPS | 121.40% | 86.13% | 80.88% | 73.34% | 63.11% |
| EPS Diluted | 114.93% | 90.33% | 88.19% | 78.94% | 68.22% |
| Normalized Diluted EPS | 120.65% | 86.05% | 80.88% | 73.34% | 63.11% |
| Average Basic Shares Outstanding | 1.81% | 2.25% | 2.35% | 2.98% | 3.59% |
| Average Diluted Shares Outstanding | 3.02% | 2.87% | 2.84% | 3.48% | 3.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |